GHRU-AMR Colombia_S. pneumoniae Clinical invasive penicillin non-susceptible Streptococcus pneumoniae isolates from National laboratory-based surveillance between 2015-2018 pre-13 PVC introduction in Colombia
This project is funded by the UK National Institute for Health Research to set up a full-fledged Global Health Research Unit (GHRU) through a grant awarded to the cGPS (Centre for Genomic Pathogen Surveillance). The aim of this project is primarily to fund research around intelligent surveillance for important emerging bacterial pathogens and monitoring the spread of antimicrobial resistance in low- and middle-income countries (LMICs) through whole-genome sequencing. The proposal would enable bacterial isolates to be collected from several regions around Colombia; their genomes assembled and analysed following WGS; not only with the aim of tracking transmission and resistance patterns but eventually in designing models that will integrate into real-time, public health 'early-warning systems'. IMPORTANT NOTE: The intellectual property rights on the biological resource used to generate this data and on the data generated from it are owned by the Colombian State, as established by the Andean Pact Decision 391 of the Andean Community of Nations, internal regulations and the provisions of the Colombian Ministry of Environment and Sustainable Development. This data may be used for scientific purposes, to generate knowledge and explain natural phenomena and processes. It shall not be used for activities relating to biological prospecting, industrial application or commercial exploitation without the prior written consent of the Colombian State. If you have any queries, you are advised to contact [Wellcome Sanger Institute] in the first instance. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/